Search results
Results from the WOW.Com Content Network
New research published in has found evidence that the use of semaglutide medications, like Ozempic may help reduce the risk of obesity-associated cancers in people with type 2 diabetes. View the ...
Ozempic and similar medications may help reduce bodily inflammation, which is a risk factor for dementia, says Verna Porter, MD, a neurologist and director of the Dementia, Alzheimer’s Disease ...
About 215,000 used GLP-1 drugs, while the rest were taking various other diabetes medications. Though semaglutides like Ozempic and Wegovy dominate the market in the U.S., Al-Aly and his team ...
The review authors noted that research into the potential brain benefits of GLP-1 medications needs more research but are optimistic about the future of these drugs in how they may boost brain health.
The success of weight loss drugs like Ozempic heavily relies on the effect that they have in your brain, too, according to doctors. This is how GLP-1s impact your mind.
A 2021 study on semaglutide in the New England Journal of Medicine found a 15% reduction in body weight, while Bustamante points to a 2022 extension of the original study, which shows that ...
The study looked at medical records of nearly 3,500 patients with obesity who were prescribed semaglutide (Wegovy, Ozempic) or liraglutide, a medication to treat type 2 diabetes that can also lead ...
If you start taking a semaglutide medication like Ozempic, doctors stress that the medications are meant to be one tool you can use, alongside other healthy lifestyle changes. Chief among them ...